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ABSTRACT 
An abstract of the thesis of Michael Patrick Brown for the 
Master of Science in Biology presented May 17, 1995. 
Title: Effect of Ototoxic Drugs on the Amphibian Auditory 
System: Injection of Gentamicin Sulfate into 
Anuran Otic Capsules and Recovery of Thresholds 
Hair cell trauma from aminoglycosides, which may lead 
to permanent loss of hair cells in mammals, was studied 
physiologically in frogs by measuring an auditory evoked 
potential (AEP) in Rana pipiens. The AEP was evaluated in 
order to measure threshold shift (TS) and recovery from TS 
after the administration of the aminoglycoside antibiotic, 
gentamicin. To obtain an AEP, chronic electrodes were 
implanted into the cranium near the cochlear nucleus. The 
frogs were then exposed to frequency-specific narrow band 
~clicks" which included a single period 1 kHz sinewave, and 
a computer synthesized high frequency and low frequency 
click. Amphibians have two hearing organs, the amphibian 
and basilar papillae, sensitive to low (150-1500) and high 
(1500-2000) frequencies, respectively. The low (AP) and 
high (BP) frequency clicks were created to stimulate 
specifically the corresponding papillae. After normal 
thresholds were recorded for each frog, gentamicin sulfate, 
200 µM, 300 µM, or 400 µM, was injected bilaterally into 
the otic capsules. Thresholds were recorded until the TS 
had disappeared, allowing the threshold recovery period to 
be measured. The injections of 200 µM yielded a 10 dB 
change in one animal and no change in two others. The 
injection of 300 µM into 10 frogs and 400 µM into 20 frogs 
yielded at least a 10 dB change in 60% and 93% of the 
frogs, respectively, with the concentration of 400 µM 
producing threshold shifts of 20 dB. Thus, the threshold 
shifts were dose-dependent. Recovery times varied between 
six and fourteen days. No apparent differences between 
thresholds for the high frequency click, low frequency 
click and sinewave clicks were observed. 
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Introduction 
In our quest to relieve the pain and suffering of 
people through the use of drugs, even though the objective 
may be reached, unexpected repercussions may occur. It 
has long been known that treatment with one class of 
antibiotic, the aminoglycosides, can cause damage to the 
auditory system (Girod and Rubel, 1991). It has been 
estimated that in the United States hearing impairment, 
frequently irreversible, occurs in as many as 5% of 
patients who have received aminoglycosidic treatment 
(Kroese et al., 1989). Despite this negative consequence, 
the particular effectiveness of aminoglycosides supports 
their continued use. For example, aminoglycoside 
antibiotics are used primarily in the treatment of 
meningitis and other serious infections (Arritola, 1995; 
Duff, 1992) . 
Hair cells of the inner ear transduce motion into 
neural signals for further nervous system processing and 
are the elements apparently damaged following chemical or 
acoustic trauma (Lefebvre et. al., 1993; Lippe et al., 
1991; Pugliano et al., 1993a). In most studies, the 
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amount of hair cell damage is assessed by sacrificing the 
animal at specific periods post-treatment and, utilizing 
electron microscopy, viewing hair cells directly (Baird et 
al., 1993; Forge et al., 1993; Raphael, 1993; Cotanche and 
Lee, 1994). This method provides a direct correlation 
between the amount of trauma induced and the number of 
hair cells damaged. A few studies have examined 
physiological measures of damage, but no studies in 
amphibians have measured physiological changes in response 
to ototoxic drugs (Baird et al., 1993; Kroese et al., 
1989) . 
In this study, I examine the effects of one 
aminoglycoside antibiotic, gentamicin, on the hearing of 
the anuran amphibian, Rana pipiens. Unlike several other 
studies, rather than systemic injection, the 
aminoglycoside was injected bilaterally into the otic 
capsules (Baird et al, 1993; Hashino et al., 1992; 
Lombarte et al., 1993). The otic capsule is a bony region 
of the head containing the auditory papillae. The drug's 
effect was monitored utilizing an auditory brainstem 
recording (ABR) method in which electrodes were implanted 
near the brainstem to detect volume-conducted potentials 
from the VIII cranial nerve and ascending auditory nerve 
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nuclei. Because the electrodes were implanted 
chronically, this method allows measurement of frog 
hearing threshold, in most cases, up to five weeks. 
Depending on the concentration, the treatments resulted in 
temporary threshold shifts (TTS), with a return to normal 
threshold within 7-14 days. 
Frogs possess two hearing organs in each ear, the 
amphibian papilla (AP) and basilar papilla (BP) (Lewis et 
al., 1992). Even though there are actually eight sensory 
organs with hair cells, only the AP and BP respond to 
acoustic stimuli. The other six are vestibular organs and 
include three semicircular canals, utricle, saccule, and 
lagena (Wilczynski and Capranica, 1984). The AP is unique 
to amphibians and is generally larger than the BP. The AP 
is most sensitive to low frequencies and the BP to higher 
frequencies (reviewed in Wilczynski and Capranica, 1984). 
Because the AP and BP are two separate organs, it is 
possible that aminoglycosides affect each organ 
differently. For example, the high frequencies may be 
affected more than the low frequencies. This is the first 
study to attempt to stimulate the AP and BP separately 
using an ABR technique. This was accomplished using 
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Hair Cells: 
Vertebrates have developed efficient neural sensory 
systems for the processing of sound. One feature common 
to these systems is the hair cell. When appropriately 
stimulated, this mechanoreceptive sensory cell converts 
changes in sound pressure to electrical signals. These 
neural signals are then transmitted to the higher centers 
of the brain for processing. In mammals, the hair cells 
are arranged on the cochlea such that they are "tuned" to 
specific frequencies. This phenomenon is referred to as 
tonotopic organization and is preserved in the neural 
pathway to the brain. However, tonotopy is not present in 
all auditory organs of different species (Cotanche et al., 
1994; Corwin and Warchol, 1991). 
Somewhat independent of tonotopic organization is the 
orientation of the hair cells. Each hair cell body has a 
base on which there is a bundle of stereovilli. The 
stereovilli determine the structural and functional 
characteristics of the bundle (Corwin and Warchol, 1991). 
In mammals, there exist four highly ordered rows of hair 
cells in the cochlea. However, not all animals have a 
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cochlea with this arrangement. For example, birds, 
reptiles and amphibians lack cochleas (Corwin and Warchol, 
1991; Corwin et al, 1993). Instead, a simpler papilla is 
found in place of the more complex cochlear organ of Corti 
and basilar membrane. Hair cells often vary in their 
orientation on a papilla and may appear to be randomly 
dispersed. In fish, hair cells are arranged in various 
ordered configurations in the sacculus (Lombarte et al., 
1993; Presson et al., 1995; Weisleder and Zakon, 1995). 
Birds posses a papilla with ordered, tuned hair cells 
which are sensitive to specific frequencies (Corwin and 
Warchol, 1991). 
In most frog species, the hair cells of the AP are 
distributed along a long "S"-shaped organ. The hair cells 
themselves possess a bundle of stereovilli with a longer 
kinocilium at one end of the bundle. The AP has an 
ordered arrangement of hair cells (Schmitz et al., 1992). 
However, the specific orientation of the hair cells may 
vary along different regions of the papilla (Lewis et al, 
1992) . The hair cells of the BP are arranged in a 
semicircle, and the kinocilium on each hair cell, is 
located on the side of the bundle with the shortest 
stereovilli. The BP hair cells all have an identical 
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orientation (Wilczynski and Capranica, 1983). The AP 
supports a traveling wave and neural tonotopy. However, 
tonotopy is not a characteristic of the BP (Corwin and 
Warchol, 1991; Hillery and Narins, 1984). 
Hair cells may be damaged by two mechanisms, acoustic 
overstimulation and ototoxicity, as caused by drug 
treatments (Abdouh et al., 1993; Aran et al., 1995; 
Duckert and Rubel, 1993a) . Acoustic overstimulation 
caused by noise exposure is a universal concern today 
because of exposure to loud music and machinery noise. 
However, ototoxicity caused by drug treatments is fast 
becoming a major problem faced by the medical community. 
The loss of hair cells by this means is responsible for 
hearing and balance deficits that affect millions of 
people (Mandell et al., 1990). Problems associated with 
vestibular toxicity include vertigo, disequilibrium, 
lightheadedness, nausea, and vomiting. Ototoxicity can 
lead to tinnitis (ringing) and temporary or permanent 
hearing loss (Smith and Swenson, 1990; Tsue et al., 1994). 
It has been estimated that approximately 5% of the 
population has hearing impairment as the result of the 
destruction of hair cells (Kroese and Bercken, 1982). 
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Aminoglycosides: 
Many drugs sold today may cause ototoxicity as a side 
effect (Duckert and Rubel, 1993a) . Aminoglycosides fall 
into this category. Unfortunately, sometimes the need for 
the medication outweighs the risk of possible side 
effects. Aminoglycoside antibiotics are the drugs of 
choice for bacterial meningitis and many other serious 
infections (Duff, 1992; Ernst and Zenner, 1992). Their 
main target is aerobic gram-negative bacilli, namely 
Pseudomonas species and virtually all strains of 
Streptococcus faecalis (Mandell et al, 1990). Besides 
nephrotoxicity and neuromuscular paralysis, all 
aminoglycosides are capable of causing ototoxicity which 
can lead to permanent hearing loss. There are several 
types of aminoglycosides which may affect hair cell organs 
differently. The mammalian vestibular system is primarily 
susceptible to damage by streptomycin and gentamicin, 
while amikacin, kanamycin, and neomycin primarily affect 
the cochlear system (Mandell et al., 1990; Wanke and 
Moore, 1991). In fact, approximately 25% of the patients 
under streptomycin treatment experience vertigo or other 
vestibular disturbances (Smith and Swenson, 1990). 
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On the molecular level, aminoglycoside antibiotics 
contain two or more aminosugars linked by glycosidic bonds 
to an aminocyclitol ring. The primary difference between 
the aminoglycosides is in the nature of the hydroxyl and 
aminosugar groups that are linked to the central 
aminocyclitol ring (Mandell et al., 1990). In general, 
the mechanism of action is the inhibition of protein 
synthesis by binding directly to the 30S ribosornmal 
subunit (Arritola, 1995). This kills the bacteria. The 
exact mechanism of action on the sensory hair cells is 
still under investigation, but it appears that the sensory 
hair cell membrane is compromised (Denk et al., 1992). In 
many instances following aminoglycoside treatment, 
morphological assessment reveals that hair cells are 
actually fused to one another (Arritola, 1995). 
Aminoglycosides can inhibit phosphoinositide 
metabolism in cell membranes and can interfere with the 
calcium binding sites in the membranes (Stiffler, 1993). 
The interference with the calcium dependent mechanisms can 
effect the actin/myosin interaction and can result in the 
shortening of the outer hair cells (OHCs) of the mammalian 
cochlea (Cecola and Bobbin, 1992; Harada et al., 1994). 
Calcium plays an integral role in hair cell metabolism, 
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cell shape, and cell excitability (Slepecky et al., 1993). 
Research on mice suggests a reduction in a calcium-binding 
protein, S-100, resulting in a disruption of calcium 
metabolism (Tahara et al., 1995). Still further research 
suggests that formation of free radicals by 
aminoglycosides leads to the destruction of hair cells 
(Clerici et al., 1995; Meiteles and Rapheal, 1994; Priuska 
and Schacht, 1995) . 
It is known that the half-life of aminoglycosides is 
approximately five to six times longer in the otic fluid 
than in the circulating plasma (Arritola, 1995). 
Irnmunohistochemical methods have demonstrated that 
aminoglycosides can specifically penetrate into the 
sensory cells (Aran et al., 1993). However, it is not 
well understood how the drugs are initially absorbed into 
the endolymph and perilymph (Walker et al., 1990). It is 
conceivable that an over-accumulation within the 
stereovilli causes the blockage of the calcium binding 
sites (Nakagawa et al., 1992; Walker et al., 1990). 
Imamura and Adams, (1995) found that after systemic and 
local injection, aminoglycosides accumulated in several 
auditory and vestibular hair cells often causing 
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disruption of cellular components such as calmodulin, S-
100, and sodium-potassium ATPase. 
Decreased carbohydrate uptake due to the presence of 
aminoglycosides may be another cause of hearing loss. It 
has been suggested that certain carbohydrates are 
important in anchoring stereovilli tip links of hair cells 
and as well as anchoring stereovilli to the overlaying 
tectorial membrane (Epstein and Cotanche, 1995; Plinkert 
et al., 1992; Tilney et al., 1992). If aminoglycosides 
disrupted the uptake of carbohydrates, normal cell 
functioning would be compromised. Of course, one must 
also realize that different aminoglycosides could each 
produce different results and different levels of 
severity. 
Current Research: 
In some animals, hair cells possess the ability to 
regenerate after auditory trauma. The regenerative 
capabilities of amphibians are well known. Unlike the 
hair cells of amphibians, for many years it was believed 
that the hair cells of both the avian and mammalian 
cochlea did not regenerate. This was first challenged by 
several studies indicating the avian cochlea is capable of 
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regenerating new sensory cells (Chen et. al., 1993; 
Cotanche and Lee, 1994). Recently, it has been 
demonstrated that under certain conditions, mammalian 
sensory epithelium may also have the ability to recover 
structurally and functionally (Cotanche et al., 1994). 
Although not as prevalent as research on amphibians 
and birds, research has also been focused on fish (Rubel 
et al., 1991; Corwin et al., 1991). However, like 
amphibians, teleost fish possess a continual post-
embryonic production of sensory hair cells (Weisleder and 
Zakon, 1995; Presson et al., 1995; Corwin et al., 1991). 
In fact, a possible correlation has been discovered 
between the number of hair cells damaged and the size of 
the fish. Lombarte et al. (1993) state "The time course 
for damage was longer in larger fish, but the recovery of 
the ciliary bundles appeared to be complete about 10 days 
after the maximal damage was seen in both the smaller and 
larger fish." The drugs were injected intramuscularly and 
the experimental animals sacrificed post-injection to 
examine the condition of the hair cells. 
In birds, there is evidence to suggest that hair 
cells can regenerate in chicks but not in the adult 
chicken. This could result from the fact that the chick 
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tissue still contains proliferating cells. The hair 
cells, the production of which normally occurs in 
embryogenesis, have been found to undergo mitosis after 
acoustic or ototoxic trauma (Raphael, 1993; Oesterle et 
al., 1993; Stone and Cotanche, 1992). 
Many of the studies on avian hair cells have used 
pure tones as the source of trauma while others have used 
various aminoglycosides as the source of trauma (Adler et 
al., 1992; Li et al., 1994; Lomax et al., 1995; Pugliano 
et al., 1993b). Aminoglycosides commonly used 
experimentally include gentamicin, streptomycin, and 
kanamycin (Duckert and Rubel, 1993b; Weisleder and Rubel, 
1993; Hashino et al., 1992). Finally, Lippe et al. (1995) 
reported that aminoglycoside toxicity not only damages the 
hair cells but also causes a loss of spiral ganglion 
cells, i.e., the auditory nerve ganglion. Loss of spiral 
ganglion cells could compromise hair cell recovery (Lippe 
et al., 1995) . 
Most of the research on avian hair cells includes the 
harvesting of hair cells and microscopic examination post-
exposure (Duckert and Rubel, 1993b; Stone et al., 1995). 
Furthermore, in most instances, the drugs being tested 
were either injected into the animal or fed to the animal. 
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Both of these methods may include a degree of uncertainty 
as to exactly how much of the drug is damaging the hair 
cells. Very few studies on birds examined threshold 
shifts using ABR techniques (Lou et al., 1994). Most of 
these use several different stimuli of different 
frequencies (Trautwein, 1995) . For example, in order to 
damage the hair cells, chicks were exposed to pure tones. 
In one particular study (Saunders et al., 1993), chicks 
were anesthetized, tracheotomized, and hearing examined 
using ABR methods. Electrodes were inserted near the 
brainstem and the animals stimulated with tones of various 
frequencies. In another study using ABR techniques and 
noise dosing, it was found that after fourteen days, the 
thresholds returned to their pre-exposure levels (Umemoto 
et al., 1993). An interesting study involved the training 
of adult quails to peck when tones were detected. 
Recovery times were then examined after exposures to pure 
tone stimuli (Niemiec et al., 1995). 
In mammals, research has been focused on monkeys, 
pigs, chinchillas and rats among others (Alles and Pye, 
1993; Ankerstjerne et al., 1995; Canlon et al., 1988; 
Quint et al., 1995). Limited research has also been 
conducted on human subjects. Recently, numerous studies 
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have focused on the proliferation of sensory hair cells in 
marrunals since hair cell regeneration in marrunals had been 
thought to be not possible. However, this has since been 
proved to be incorrect (Abdouh et al., 1993; Cotanche and 
Lee, 1994; Forge et al., 1993; Lefebvre et al., 1993; 
Warchol et al., 1993). Normally, the production of hair 
cells is completed at the end of the first half of the 
gestation period. However, repair of stereovilli after 
damage suggests the capability for replacement of hair 
cells in the marrunalian cochlea (Lefebvre et al., 1993). 
Some of the initial research supporting the 
regeneration of marrunalian hair cells was conducted on 
rats. However, research on guinea pigs and chinchillas is 
now very corrunon (Pye and Collins, 1991). Lefebvre (1993) 
found that retinoic acid has the capability to stimulate 
the regeneration of hair cells in rats following damage to 
the hair cells by aminoglycoside drug treatment. Other 
studies have also found a correlation between retinoic 
acid and hair cell production (Kelley et al., 1993). Few 
studies examine drug effects or noise dosing effects using 
ABR methods (Hiel et al., 1993; Ma, 1990). As for birds, 
much of the research on marrunals involves the sacrificing 
of the animal in order to examine the hair cells 
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microscopically (Lefebvre, et al., 1993; Meza-Ruiz et al., 
1995; Quint et al., 1995). 
Research on humans has been limited to subjects 
receiving drug treatments (Cheung et al., 1990). Of 
course, neither examination of the hair cells nor single-
unit recording is feasible in humans so, ABR methods are 
utilized. Throughout the drug course for patients 
receiving aminoglycosidic treatment, ABR data was 
collected for early detection of ototoxicity (Fausti et 
al., 1992; Salonna et al., 1992). This study not only 
provides valuable data for humans, but can also be used to 
help determine safe therapeutic levels before the 
ototoxicity or nephrotoxicity occur (Shrimpton et al., 
1993) . 
Anatomy of the Frog: 
Even though there are similarities between the 
mammalian and anuran ear, there are major external ear and 
inner ear differences. While anuran amphibians do not 
have a pinna, most possess tympanic membranes contiguous 
with the skin. Rather than three middle ear ossicles, 
there is usually a single columella which mechanically 
links the tympanum to the inner ear fluid space. Anurans 
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also have two auditory organs, the amphibian papilla (AP) 
and the basilar papilla (BP) (Wilczynski and Capranica, 
1984). The AP is sensitive to low frequencies in the 
range of 100 to 1500 Hz while the BP is sensitive to 
higher frequencies in the range between 1500 and 5000 Hz 
(Duellman et al., 1986). These ranges often vary from 
species to species and sometimes between sexes. The AP is 
generally larger than the BP. The AP hair cells possess 
both efferent and afferent synapses. The BP receives only 
afferent fibers (Flock and Flock, 1966; Simmons et al., 
1992; Sobkowicz and Slapnick, 1994). Like birds, new hair 
cells are produced at a low level throughout life in 
amphibians (Kelley et al., 1992). 
Research on Frogs: 
Even though much has been studied about ototoxicity 
and regeneration in the auditory system of various 
animals, much of the focus has been on mammals, birds, and 
fish. Of the smaller amount of research carried out on 
amphibians, most studies have examined bullfrogs, Rana 
catesbeiana (Hernandez et al., 1995; Northcutt and Ronan, 
1992; Seaman, 1991). Some of these studies have examined 
the effects of aminoglycosides on the morphology of 
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auditory hair cells (Baird et al., 1993; Kroese et al., 
1989) . The present study is unique in being the first to 
examine, albeit indirectly, the physiological consequences 
of aminoglycoside treatment on the frog auditory system. 
This is also the first study to use high frequency and low 
frequency clicks to evoke specific amphibian or basilar 
papilla responses. 
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Methods and Materials 
The leopard frog Rana pipiens (Charles D. Sullivan 
Company, Nashville, TN) was utilized exclusively for this 
study. All animals were medium size adults (2 1/2 - 3 
inches). All conditions and environments were 
standardized and kept constant. After shipment, the 
frogs were promptly placed in 20" x 10" tanks (usually 
five per tank). The temperature varied between 27-30 
degrees Celsius. Approximately five crickets were fed 
weekly to each frog starting on their day of arrival. 
The mean mass ± standard deviation of the frogs was 43.3 
± 5.4 grams. Each test animal underwent surgery for 
electrode implantation between 3-10 days after arrival. 
After the surgeries and for the duration of testing, the 
frogs, in groups of three, were transferred to 8" x 16" 
tanks. 
The frogs were implanted under anesthesia (TMS, 3.0 
mM, bicarbonate buffered) and placed dorsal side up on 
ice during the surgery to slow blood flow. The electrode 
implants consisted of three wires which performed the 
21 
following functions: active-1, active-2 and reference. 
Each electrode consisted of a 2.5 cm length of teflon-
insulated seven-strand stainless steel wire (.15 mm in 
diameter, A-M systems). Approximately 10.0 mm of the 
insulation was removed from one end of the wire for 
amplifier connection. The implanted end of the electrode 
was stripped of 0.5 mm of its insulation. The active-1 
electrode was placed within the cranium near the cochlear 
nucleus, the active-2 near the dorsal lymphatic sac, and 
the reference placed medially, between the eyes. The 
active electrodes were placed so as to detect the largest 
possible BAEP (Brainstem Auditory Evoked Potential). 
This placement was determined by trial and error. A 25 
f.Un diameter drill bit was used to drill three holes 
through the cranium to provide access to the brain. Once 
positioned, the electrodes were sealed in place with 
cyanoacrylate adhesive (Nexaband Opthalmic} and dental 
cement. Once dried, the electrode cap and electrode 
bases were coated (Plasticdip) for added stability. For 
identification of the frogs a color code system was 
utilized. A combination of three colored beads was 
allowed to dry in the electrode cap created by the dental 
cement and Plasticdip. Animals were allowed 48 hours 
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minimum recovery before testing. Commonly, the frogs 
exhibited normal behavior within 12 hours following the 
surgery. The implants usually lasted from three to six 
weeks. Each experiment was performed in a sound isolated 
room (IAC 1200 series). 
The sound producing equipment consisted of a 
computer controlled "click" generator (Macintosh, GW 
instruments), equalizer (Rane FPE 13 Parametric), 
amplifier (Hafler P230) and loudspeaker (Radio Shack 
Minimus 7.0). Figure 1 shows the stimulus and recording 
equipment arrangement. The speaker was hung one meter 
directly above the test-frog. This arrangement enabled 
both tympani of the frog to be stimulated equally. The 
signal recording equipment consisted of signal amplifiers 
(Precision Instruments DAM 80, Tektronix 26A2) and a 
Digital Signal Analyzer (Tektronix DSA-601A). The 
amplifiers were bandpass limited (1 Hz - 3000 Hz). Using 
this arrangement, the brain signal was amplified 
approximately lOOOOx. The sound from the speaker at the 
position of the test animal was monitored using a 
measurement microphone and filter/amplifier(ACO Pacific 
and Krohn-Hite 3700). 
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The averaging process was sophisticated in that a 
copy of the brain signal was routed to a custom-designed 
"artifact reject" circuit. This circuit validated the 
trigger pulse for averaging following each presentation 
of a stimulus click. Validation occurred only if the 
brain signal remained within a preset limit adjusted to 
be lower than muscle-generated artifacts present during 
any locomotor behavior. The circuit effectively looked 
back in time to examine the incoming signal from the 
brain. In this way, transient movement of the frog did 
not impair the on-going average and much time was saved 
during testing. If the brain signal contained too much 
artifact, from frog movement for example, the signal 
would not be averaged. Typically, between 250 and 500 
averages were required, depending on the signal/noise 
ratio for the animal. 
My method of determining thresholds for frogs 
utilized a visual detection method (Carey and Zelick, 
1993) with a variation (step size) of the method of 
adjustment technique. This process involved starting 
with a loud click (20 dB attenuation, 94 dB SPL) and 
increasing the attenuation in large steps (20, 10, 5 dB 
attn) (decreasing the dB SPL level) until no ABR was 
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seen. When no ABR was present, the attenuation was 
decreased until the ABR was once again present. Thus, a 
combination of over- and under-shooting was used in order 
to determine the threshold point. 
Since the aminoglycosides may affect the amphibian 
and basilar papillae differently, specific clicks were 
generated so as to stimulate the AP, BP, or both. Thus, 
the frogs were exposed to three different test stimuli 
(Figure 2-5) . The first of the clicks was a single-
period 1 kHz sinewave click. This click was generated 
from a waveform generator (TDT WGI) and for abbreviation 
is referred to as the "WGI" click. This click 
encompassed a wide band of frequencies sufficient to 
stimulate both the AP and BP while the two other clicks, 
a low frequency and high frequency click, were 
specifically designed to stimulate the amphibian and 
basilar papillae, respectively (Figure 6-8). A pulse 
generator (Krohn-Hite 2100) was used to trigger both the 
computer generated clicks as well as the waveform 
generated click at a rate of 11 per second which was 
found to be optimal in a previous study (Carey and 
Zelick, 1993) . The computer generated clicks are 
referred to as the "AP" and "BP" clicks. 
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The AP and BP clicks were actually composites of 
multiple sine waves (over the desired range). The sine 
waves were of coincidental phase at the middle of the 
click. Given the limitations of the computer and the 
mathematics involved, approximately 24 Hz steps were 
utilized between sinewaves. For example, if the first 
frequency was 200 Hz, the second would be 224 Hz, 
followed by 248 Hz, and so on. The composite sinewaves 
produced a "train" of pulses as a consequence of falling 
in and out of phase with each other (constructive and 
destructive interference). A single pulse was sliced out 
of the "train" and further refined by applying a Hanning 
Window (cosine squared wave) . This produced a click of 
the desired duration and spectral composition. 
Initially, all of the frogs underwent sound testing 
to establish base-level "normal" ABRs for all three 
clicks and to determine the thresholds for each frog. 
Each frog was utilized as its own control in subsequent 
tests. Approximately six days of determining thresholds 
were needed per frog in order to establish each frog's 
normal thresholds. After normal thresholds were 
obtained, each test animal was injected with gentamicin 
sulfate (Sigma). Unlike several other studies on birds, 
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fish, and amphibians in which gentamicin was injected 
systemically, a bilateral intraotic administration of 
gentamicin was utilized (Baird et al., 1992; Weisleder 
and Rubel, 1993; Lombarte et al., 1993). This method 
eliminated the possibility of systemic overdosage 
resulting in toxicity and other side effects. In 
addition, the intraotic administration permitted more 
certain control of dosage and destination of the 
gentamicin. 
Using the intraotic approach required an estimation 
of the mean otic capsule volume in order to establish the 
final concentration of the gentamicin within the otic 
capsule (Table 1). This is the first time gentamicin was 
injected intraotically in this frog species. This also 
provides the approximate intraotic concentration of 
gentamicin. Several different frogs were utilized to 
provide a random sample. Four different methods were 
utilized to determine the otic capsule volume. The first 
method consisted of drilling two holes into each otic 
capsule. Dye was injected into one of the holes. When 
the dye was displaced from the second hole, the volume of 
dye injected was recorded. The second method involved 
drilling one hole into the otic capsule followed by 
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suction removal of the fluid inside the capsule. The 
volume of fluid removed was recorded. Both of these 
methods utilized a Hamilton syringe for precise 
measurement. The third and fourth method involved the 
removal of the entire otic capsule. After the connective 
tissue was scraped away, the dimensions were recorded. 
The approximate volume was calculated assuming the 
capsule was (1) cuboidal, or (2) spherical. Averaging 
all four methods, the volume was estimated to be 16.8 µl 
± 4.3 (SD). For the drug calculations, 15 µl was 
utilized, to compensate for internal tissue and organs. 
The gentamicin solution was dissolved in low-calcium 
HEPES-buffered saline (118 rnM sodium, 2 rnM potassium, 118 
mM chloride, 4 mM D glucose and 10 mM HEPES dissolved in 
distilled water}. Control frogs were injected with the 
HEPES-buffered saline alone. Test frogs were injected 
with the HEPES solution with varing concentrations of 
gentamicin sulfate. Three different concentrations of 
gentamicin were utilized. The initial concentrations of 
750 µM, 1125 µM and 1500 µM were injected to yield 
approximate intraotic concentrations of 200 µM, 300 µM 
and 400 µM respectively (see appendix for calculations). 
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The gentamicin received from Sigma contained components 
of Cl, C2 and Cla with molecular weights of 477, 466 and 
449 respectively. An average of 464 grams/mole was 
utilized (Kroese et al., 1989). 
The injections were made bilaterally into the otic 
capsule under TMS anesthesia. To gain access to the otic 
capsules, frogs were placed ventral side up with the jaw 
held open using padded paperclips. This also kept the 
tongue away from the incision area. The connective 
tissue and muscle was scraped away in order to expose the 
otic capsule. A drill (45 µm diameter) was used to 
perforate the capsules. Two holes were drilled per 
capsule. This allowed the excess fluid to be displaced. 
A Hamilton syringe (10 µl) was introduced into one of the 
holes and four microliters of the solution was carefully 
injected. The holes were covered with dental cement and 
the frogs were allowed to recover overnight. Testing for 
thresholds was continued the following day until the 
thresholds returned to the frogs' normal values. 
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Figure 1. Stimulus and recording arrangement for obtaining ABRs. The clicks, 
generated by the computer and waveform generator, are triggered by the pulse 
generator. The clicks are amplified to drive the speaker. The brain signals are 
amplified and any artifact present is rejected by the signal reject circuit. The signal is 
averaged and viewed with the digital signal analyzer. The microphone is used to 
monitor the clicks. 
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Figure 2. Electrical representations of the AP click (top) and BP click (bottom). 
Note durations are less then 3 ms. The Y-axis is arbitrary voltage units. 
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Figure 3. Time relationship of test signals. The top trace shows the triggers for the 
click generator which produces a sinewave (second trace). The third trace is the 
resulting ABR The fourth trace is the validation signal (arrow; see methods). This is 
also triggered by the main trigger (top trace). The bottom trace is the acoustic signal 
picked up by the microphone. Notice the delay between the original click, the 
microphone, and the ABR signal produced. The Y-axis is arbitrary units. 
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Figure 4. Similar to the previous figure (Figure 4), the trigger (top trace) causes the 
computer to generate a click, here, the AP electrical signal (second trace). The ABR 
waveform morphology (third trace) is different then that of the WGI ABR 
morphology. The fourth trace represents the validation signal. The last trace is the 
microphone signal. 
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Figure 5. BP click. Traces same as Figure 4. The ABR (third trace) has a different 
waveform morphology than the WGI or AP clicks. 
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Figure 7. Top: A single period sinewave click (IDT click). Bottom: The 
corresponding frequency spectrum. This spectrum (averaged 512 times) is normal 
and characteristic of such a click. All Y-axis units are arbitrary voltage units. 
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Method I - Injected Ink 
Frog# amt. injected 
Frog 1 16 
15 
Frog2 18 
19 
Frog3 14 
13 
Frog4 13 
Frog5 25 
Mean: 16.6 
St. Dev: 4.0 
Metbocl Ill - ca1c. of Sphere 
F!!i# 
Frog 1 
Frog2 
Frog3 
Mean: 
St. Dev: 
Otic capsule Volume 
12.1 
7.8 
14.7 
14.8 
11.1 
9.7 
11.7 
2.7 
Mean of Method I-IV: 11.I 
Standard deviation of Method I-IV: 4.3 
Method II - Suction Removal 
Frog# 
Frog 1 
Frog2 
Frog3 
Mean: 
St. Dev: 
amt. removed 
18 
17 
13 
15 
20 
16.6 
2.7 
Metbod IV- Cllc. of Cube 
F!!i# 
Frog 1 
Frog2 
Frog3 
Mean: 
St. Dev: 
Otlc capsule Volume 
23.1 
14.8 
28.1 
27.9 
21.2 
18.8 
22.3 
5.2 
Table L The four methods for the estimation of the otic capsule volume. 
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Results 
ABRs: 
ABRs from a typical single frog recorded from pre-
treatment through 14 days post-treatment are shown in 
Figures 9-12. The addition of gentamicin has an obvious 
effect on the ABR morphology. Absolute peak latencies 
shift accordingly with the changes in sound pressure 
level (SPL). With a decreased SPL (increased 
attenuation), the latencies increased and the amplitude 
of the ABRs decreased. The corresponding threshold 
shifts are plotted (Figure 13 top) . The ABRs showing the 
waveform morphology changes correspond to two days before 
treatment and three, 10 and 13 days post-treatment. This 
test included only the WGI click. A typical frog showing 
threshold shifts for injections of 300 µM gentamicin 
concentrations is also shown (Figure 13 bottom) . These 
data include threshold shifts for the AP and BP clicks in 
addition to the WGI click. 
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Threshold and Recovery: 
Figure 14 shows the control and mean of frogs 
receiving 200 µM gentamicin concentrations. The time 
scale does not completely correspond to that in the other 
trials since the control frogs were injected with the 
HEPES-buffered control solution five days prior to the 
test frogs. As expected, the control group showed little 
change in threshold. The mean threshold shift for frogs 
receiving 200 µM gentamicin injections was approximately 
five dB. Only three frogs were used for the 200 µM 
injections. Because the shift was small and had no 
effect on one of the frogs, it was decided to increase 
the concentration to 300 µM. Baird et al. (1993) found 
that this concentration of gentamicin had little or no 
effect on the morphology of frog vestibular hair cells. 
Two different groups of frogs received 300 µM 
gentamicin injections (Figure 15-16). However, only one 
control group was utilized which showed no significant 
threshold change. A total of 12 frogs was utilized for 
the 300 µM trials. The mean threshold shift for frogs 
receiving 300 µM gentamicin injections was between 5-10 
dB. 
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In frogs receiving 400 µM drug treatments, threshold 
shifts of 10-20 dB were observed (Figure 17-18). More 
than 20 frogs were utilized for the 400 µM trials. The 
first trial of 400 µM injections produced pronounced 
threshold shifts for which total recovery was not 
observed. This is attributed to high frog mortality. 
Unlike their responses to other drug concentrations, 
erratic frog behavior was noted for the first time with 
the 400 µM concentration of gentamicin (first trial 
only) . A total of eight frogs was utilized for trial 
one, six test animals and two controls. Two frogs, 
including a control frog died on the third day. On the 
fifth day, another test frog died. Before they died, all 
of the frogs appeared "sickly." They also exhibited 
balance problems and were leaning to one side. Often, 
one leg would be outstretched. They did not jump and 
remained still. This included not trying to jump out of 
tanks even when the lids were removed, a behavior 
uncharacteristic for frogs. Before the thresholds could 
completely recover, most of the frogs died. No adverse 
vestibular effects were observed with the second trial of 
400 µM frogs. 
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In all trials, threshold shifts were seen as early 
as one day post-injection. Also, recovery began between 
day three and five post-injection. In both 300 µM trials 
and the first trial of 400 µM, threshold increases were 
seen approximately six days post-injection. 
Not only did the threshold shifts depend on the 
dosage concentration of gentamicin; they were also 
potency dependent. For example, trial two of the 300 µM 
(Figure 16) injections utilized yielded a smaller change 
in threshold than the first trial. The gentamicin 
solution made for this trial was the same used for the 
first 300 µM (Figure 15) trial and was two weeks old. 
The potency effect is also obvious from mean threshold 
differences between the two 400 µM (Figure 17-18) 
concentration trials. The gentamicin solution used for 
the second 400 µM trial was six days old. However, the 
second 400 µM trial shows significant threshold shifts. 
It should be noted that on graphs showing threshold 
shifts (Figure 14-18), three pre-treatment thresholds 
(day -3, -2 and -1) were averaged. Thresholds recorded 
three days pre-treatment were usually stable and 
represented a "normal" threshold. Each threshold 
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measurement was normalized by subtracting the measurement 
from the pre-treatment average. The means for each frog 
were plotted and standard deviations were calculated for 
all trials except for the controls and the 200 µM trial 
(Figure 14 bottom). 
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Figure 9. ABR responses recorded two days pre-treatment with gentamicin. 
Numbers on the right correspond to decibels (dB) SPL. 
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Figure 13. Top: Threshold change and recovery over 20 days. Days marked with 
an asterisk correspond to ABR data from same test animal as Figure 9-12. Bottom: 
Typical threshold from one frog receiving 300 µM gentamicin concentration showing 
similarity of threshold change for AP and BP. 
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Figure IS. Top: Control group for 300 µM frogs. Bottom: Trial One threshold 
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Discussion 
The evoked potential or ABR technique can be used as 
an assay for the performance of the ascending auditory 
pathway. The ABR technique in frogs allows long-term 
recording of auditory function. I found that it is 
important to wait at least 24 hours following 
implantation of electrodes before threshold measurements 
are recorded. Although the animals appeared awake and 
active only five hours post-implant, the thresholds were 
found to be higher than those measured subsequently. 
Occasionally, even 36 hours after frogs were implanted, 
thresholds would be higher than normal. For this reason, 
thresholds were monitored for three to five days to be 
sure stable low thresholds were obtainable. Figure 15 
and 16 (top), the 300 µM control averages, demonstrate 
how a gradual threshold decrease occurs with time. 
Aminoglycosides caused presumed destruction of hair 
cells as early as one day post-treatment, with a maximum 
effect observed between three and five days. Often, total 
recovery is seen between 14-20 days in frogs and birds 
(Baird et al., 1993; Chen et al., 1993; Hashino et al., 
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1991). In my study, the same time course of effect 
existed for the threshold shifts observed in all trials. 
Unfortunately, threshold recovery within the two week time 
period did not occur with all frogs because several frogs 
sickened and died. Even though Baird et al. (1993) found 
that bullfrogs (Rana catesbeiana) did not survive 400 µM 
injections, I believe that an infection was to blame for 
the high frog mortality initially observed with Rana 
pipiens givien a similar dose. This is supported by the 
observation that a control otic puncture frog also died. 
In order to combat any infections that might have affected 
the frogs, prophylactic antibiotic (non-aminoglycosidic 
tetracycline) treatments were administered in later 
experiments. Mortality and sickness decreased markedly as 
seen with the second trial of 400 µM frogs. In fact, the 
frogs showed no signs of sickness, balance problems, or 
lack of activity. Of the trials conducted before the 
tetracycline treatments, frog thresholds often never 
reached normal threshold due to sickness and death. 
Vestibular toxicity due to aminoglycosidic treatment 
leads to behavioral changes associated with balance 
deficits (Honda et al., 1991; Tsue et al., 1994; Walker et 
al., 1990). In frogs, the observations include 
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instability of the head and consequent deterioration of 
jumping ability. Other behaviors noted were abnormal 
posture and swimming (Suzuki et al., 1991). Research on 
rats after aminoglycosidic treatment documents vestibular 
deficiencies ranging from diminished swimming ability to 
prolonged latency for righting responses (in air) and 
resurfacing in water, compared to controls (Ruiz-Meza et 
al., 1995). 
In this study, before the prophylactic drug 
treatments, several frogs succumbed to a possible 
infection and died. Abnormal behavior such as balance 
problems and lack of activity was observed. However, 
these symptoms were not observed in the frogs that 
received 200 and 300 µM gentamicin injections. Only the 
first trial of 400 µM test frogs exhibited these 
characteristics. Frogs treated prophylactically with the 
tetracycline following otic puncture appeared healthy 
through the duration of the experiment. 
As discussed earlier, this is the first research to 
examine the possibility of stimulating only the amphibian 
or basilar papillae using an AP-selective and BP-selective 
stimulus. From my data it is clear that substantial 
threshold differences between the WGI click and the AP and 
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BP clicks do not exist. This similarity of sensitivity is 
not consistent with tuning data of Feng et al. (1975). 
Furthermore, there was no difference observed between the 
AP and BP in their response to gentamicin (Figure 13-17). 
There is variation among animals in the AP and 
particularly BP frequency range (Duellman et al., 1966; 
Feng and Shopner, 1981; Hetherington, 1992; Megela and 
Capranica, 1981). Thus, it is possible that the frequency 
composition of the clicks was such that they were not 
specific enough to evoke responses exclusively from one or 
the other papilla. If however, there is truly no 
difference in drug response by the two papillae, this 
suggests that any differences in AP and BP hair cells, and 
the organs themselves, do not confer relative protection 
from aminoglycoside trauma. What are the differences 
between the AP and BP? They both lie in their own chamber 
and are separated. Lewis et al. (1982) found that even 
though both papillae are innervated by the eighth nerve, 
axons in the AP connect 10-15 hair cells while in the BP 
one axon innervates one hair cell. The AP hair cells are 
specifically tuned to frequencies in the range from 100 Hz 
to 1000 Hz while the BP is tuned to higher frequencies 
(Schmitz et al., 1992). However, it should be noted that 
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the data of Schmitz et al. (1992) on characteristic 
frequencies were based on pure tones, not clicks. As in 
mammals, the AP has tonotopic organization. Even though 
these organs are very different in morphology, it appears 
the gentamicin can affect both equally. If indeed, as 
several studies indicate (Aran et al., 1993; Nakagawa et 
al., 1992; Stiffler, 1993; Tahara et al., 1995), 
aminoglycosides alter binding sites on plasma membranes 
leading to disruption of normal cell metabolism, then we 
can conclude that despite various physiological 
differences between hair cells, the membranes of all types 
share sufficient similarities resulting in similar 
aminoglycoside effects. 
A further consideration is the fact that the AP and 
BP clicks produced ABRs with different waveform 
morphology. The only effect gentamicin appeared to have 
on the ABRs from all three clicks was a reduction of 
amplitude. Characteristic of a typical frog ABR is four 
peaks. Like humans, which typically have seven peaks, the 
exact origin of all peaks in frogs is unknown. 
The reduction in amplitude of the peaks due to the 
gentamicin was especially pronounced in the first peak. 
This is to be expected since the damage is occurring at 
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the hair cell level. The amplitude of peak I and 
subsequent reduction is clearly demonstrated in Figure 9-
12. Recovery of the hair cells returns peak I to nearly 
pre-treatment amplitudes. The same phenomenon occurs to a 
degree with peaks II-IV. 
Normally, the waveform morphology is very similar for 
the WGI and AP click. This is readily explained since 
most of the contribution to the overall evoked potential 
elicited by the WGI click comes from the AP, the organ 
with more hair cells. Typically, peaks I-IV are all 
present and approximately the same amplitude. However, 
the BP response differs in that the peaks are often less 
defined and have slightly smaller amplitudes. In 
addition, the distance between peaks, interpeak latency, 
can be longer with the BP waveform. 
There may also be morphological differences between 
the actual hair cells that may determine the ototoxicity 
from the aminoglycoside. Baird et al. (1993) found that 
within the vestibular organs, hair cells in the central 
regions are more sensitive than hair cells in the 
peripheral regions. He also found that hair cells of the 
different auditory organs differ significantly in the hair 
bundle morphology in different membrane regions. Thus, it 
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is possible that the number of stereovilli and the size of 
the kinocillium may determine a particular hair cell's 
susceptibility to aminoglycosides. 
My data has definite correlations with current 
research on hair cell damage. In bullfrogs, Baird et al. 
(1993) found that within ten days post-injection, the 
cellular morphology in the gentamicin-injected animals 
closely resembled that seen in normal animals. In fact, 
he observed that the cell bodies of hair cells and 
supporting cells were more ordered and normal in 
appearance. In birds, several studies indicate that 
within 14 days, significant hair cell regeneration had 
occurred (Chen et al., 1993; Hashino et al., 1992; 
Weisleder and Rubel, 1993). Forge et al., (1993) report 
that by seven days post-gentamicin injection in guinea 
pigs, most of the hair cells in the striolar region were 
replaced completely. While these studies might support my 
data, it should be noted that they all involve multiple 
doses of aminoglycosides. Only the methodology of Baird 
et al. (1993) involves giving a single dose of 
aminoglycoside. 
Research has demonstrated that some aminoglycosides 
affect hair cells differently, depending on their location 
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:' 
within the vestibular or cochlear system (Mandell et al., 
1990; Tsue et al., 1994; Wanke and Moore, 1991). The 
effects do not appear to be species specific. For 
example, hair cells in the vestibular system of humans and 
anurans are particularly susceptible to gentamicin (Baird 
et al., 1993; Smith and Swenson, 1990; Weisleder and 
Rubel, 1993). However, Cotanche et al. (1993) report that 
the avian, budgerigar, cochlear hair cells are more 
sensitive to gentamicin that kanamicin (60% vs. 35% 
damage). Hashino et al. (1992) also found that gentamicin 
can have a prolonged and progressively more damaging 
effect on hair cells for several weeks after the end of 
drug treatment. However, in these avian studies, the 
aminoglycosides were given in multiple doses over 10 days. 
Perhaps the damage to the hair cells depends upon the 
dosing schedule. Smith and Swenson (1990) report that all 
aminoglycosides will produce cochlear and vestibular 
toxicity if high concentrations are maintained in the 
inner ear. Certainly, aminoglycosides given over 10 days 
compared to one single treatment may affect the vestibular 
and cochlear hair cells differently. Baird et al. (1993) 
found that within two days treatment with 200 µM 
gentamicin, hair cell density in the sacculus was zero and 
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in the utricular striola hair cell density was about 25% 
that of control bullfrogs. This supports the fact that 
gentamicin affects the vestibular system more than the 
cochlear system and by the fact that my data shows only a 
20 dB reduction in threshold. Thus, not all cochlear hair 
cells were destroyed since ABRs were still produced even 
at gentamicin concentrations of 400 µM. 
Perhaps, further research will yield a method with 
which to maximize the drug's antibiotic effects and 
minimize the trauma it causes the auditory system. It is 
also conceivable that in the future, a method to promote 
hair cell regeneration could be developed. Some studies 
have shown that vitamin C and proper dietary intake may 
reduce the ototoxic effects of aminoglycosides on the hair 
cells (Lautermann et al., 1995). Other research has 
examined the effect of growth factors on hair cell 
proliferation (Saffer and Corwin, 1995; Yamashita et al., 
1995) . Hopefully, further research will provide the 
answers to the exact mechanism of action of 
aminoglycosides on hair cells and what makes hair cells 
susceptible to ototoxicity. 
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Conclusion 
Well known for their ototoxic effects, the 
aminoglycosides destroy neural sensory hair cells. The 
injection of gentamicin into the otic capsules of Rana 
pipiens caused threshold shifts. In this study, hearing 
thresholds were measured using an ABR technique. This was 
the first study to selectively evoke a brainstem response 
from the two auditory organs using computer synthesized 
low and high frequency clicks. A broadband sinewave click 
was also used. No apparent differences in threshold 
between the AP, BP or the sinewave click were observed. 
Pre- and post-gentamicin injection thresholds were 
measured until thresholds recovered. After the intraotic 
administration of gentamicin, I found the dose- and 
potency-dependent thresholds returned to their pre-
treatment thresholds within 14 days. The injection 200 µM 
gentamicin produced threshold shifts of 10 dB. The 300 µM 
injections resulted in 10-15 dB threshold shifts. 
Injections of 400 µM gentamicin yielded a threshold shift 
as great as 20 dB. Recovery of threshold began between 
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one and three days and total recovery occurred within 14 
days post-injection for typical frogs. 
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Appendix 
Concentration Calculations 
200µM Concentration: 
([con] initial) (Volinitial) = ([con] final) (Volfina1) 
( [con] initial) ( 4µ1 ) = ( 2 0 0 µM ) ( 15 µl ) 
([con] initial) =750µ.M 
300µM Concentration: 
([con] initial) (Volinitia1) = ([con] final) (Volfina1) 
([con] initial) ( 4µ1 )=( 300µ.M ) ( 15µ1 ) 
( [con] initial) =112 5µ.M 
400µM Concentration: 
([con] initial) (Volinitia1) = ([con] final) (Volnna1) 
([conJinitia1) ( 4µ1 )=( 400µM ) ( 15µ1 ) 
([con] initial) =1500µM 
Sample calculation for 400µM GS concentration: 
1. We want 1500µ.M =10-6 moles and 1500µ.M =.0015 moles 
2. We also want to make 10 ml of solution (0.010 L) 
so, how many moles do we need to make a 0.0015 molar 
solution? (molar = mol/L) 
3. (.010 L ) x (.0015 mol/1.0 L) = 0.000015 moles GS 
4. Now, how many grams in 0.000015 moles? 
5. MW of GS = 464 grams/mole 
6. (.000015 moles GS) x (464 g/mol GS) = .00696 g = 6.96 mg 
7. However, the GS is only 652 µg gentamicin base per mg. 
8. Thus, we divide 6.96 mg by .652 to yield 10.67 mg. 
9. Thus, we add 10.67 mg of GS to 10 ml of HEPES-buffered 
saline solution. 
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